We are live on
!
Find out more
GA
Gagnon Advisors Portfolio holdings
AUM
$157M
1-Year Est. Return
36.77%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.77%
3 Year Est. Return
+129.26%
5 Year Est. Return
+121.36%
10 Year Est. Return
+1,705.4%
AUM
$154M
AUM Growth
-$10.7M
(-6.5%)
Cap. Flow
-$5.58M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
54.87%
Holding
34
New
1
Increased
8
Reduced
11
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZUO
Zuora, Inc.
ZUO
|
+$3.58M |
| 2 |
Heron Therapeutics
HRTX
|
+$2.25M |
| 3 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$2.16M |
| 4 |
ETWO
E2open Parent Holdings
ETWO
|
+$1.76M |
| 5 |
Freshworks
FRSH
|
+$1.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
|
+$4.67M |
| 2 |
Pacira BioSciences
PCRX
|
+$3.06M |
| 3 |
Ameresco
AMRC
|
+$1.84M |
| 4 |
Celcuity
CELC
|
+$1.65M |
| 5 |
Navigator Holdings
NVGS
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36% |
| 2 | Healthcare | 25.84% |
| 3 | Industrials | 17.88% |
| 4 | Energy | 12.89% |
| 5 | Real Estate | 2.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIRO
26
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $1.66M | 1.08% |
379,420
-80,184
| -17% | -$259K |
|
|
PSIX
27
Power Solutions International
PSIX
$905M
| $1.12M | 0.73% |
659,680
+33,096
| +5% | +$56.2K |
|
28
GeneDx Holdings
WGS
$2.82B
| $649K | 0.42% |
22,397
-22,397
| -50% | -$1.03M |
|
|
ETWO.WS
29
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
| $510K | 0.33% |
499,818
+219,502
| +78% | +$289K |
|
|
WGSWW
30
DELISTED
GeneDx Holdings Warrant
WGSWW
| $56K | 0.04% |
246,365
| – | – |
|
|
SLGCW
31
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $45K | 0.03% |
102,594
| – | – |
|
|
32
Celcuity
CELC
$4.05B
| – | – |
-181,353
| Closed | -$1.65M |
|
|
33
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$211M
| – | – |
-184,204
| Closed | -$4.67M |
|
Similar funds
DFS
PTFIS
AIG
CM
SFSG
AWMG
BCI
LDNAM
Gagnon Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Gagnon Advisors held 34 positions worth $154M, down 6.5% from $165M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Gagnon Advisors withdrew a net $5.58M in Q3 2022, closing 2 positions and reducing 11 holdings. Its most notable exit was Direxion Daily 20+ Year Treasury Bear 3X ETF, an estimated $4.67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Gagnon Advisors opened a new position in Heron Therapeutics worth $2.43M.
- Gagnon Advisors's largest Q3 2022 buy was Heron Therapeutics: 576,206 shares worth $2.43M.
- Gagnon Advisors added most to Zuora, Inc. in Q3 2022, an estimated $3.58M increase.
- Gagnon Advisors's biggest Q3 2022 reduction was Pacira BioSciences, cutting an estimated $3.06M.
- Gagnon Advisors fully exited Direxion Daily 20+ Year Treasury Bear 3X ETF in Q3 2022, selling an estimated $4.67M.
- Gagnon Advisors's ten largest holdings make up 55% of its $154M portfolio in Q3 2022.
- Gagnon Advisors opened 1 new position and closed 2 in Q3 2022.
- Gagnon Advisors's portfolio value fell 6.5% quarter-over-quarter to $154M.
Based on Gagnon Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.